rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

XBiotech Inc.

XBIT · Nasdaq

Health CareBiotechnologyNot moving yet

XBIT stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 12.9% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−14 points in four weeks); Health Care: 28% (−9 points in four weeks).

SEC filings

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
18% -14 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
35 (-1)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

21 Apr – 20 Oct
18%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders35-1 on the quarter
New · exited4 · 5
Reported value$4.5M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 2026321,146$739K+28,042+9.6%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026214,116$493K-16,904−7.3%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026200,182$460K-789−0.4%
RBF Capital, LLCunchanged · filed 14 Aug 2026198,501$457K00.0%
MORGAN STANLEYreduced · filed 13 Aug 2026147,880$340K-17,674−10.7%
BRIDGEWAY CAPITAL MANAGEMENT, LLCunchanged · filed 14 Aug 202698,447$226K00.0%
VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 202692,365$212K+789+0.9%
MILLENNIUM MANAGEMENT LLCreduced · filed 14 Aug 202679,330$182K-26,210−24.8%
STATE STREET CORPunchanged · filed 7 Aug 202673,006$168K00.0%
NORTHERN TRUST CORPreduced · filed 13 Aug 202666,258$152K-9,829−12.9%
31 Mar 2023 – 30 Jun 2026
314049Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Craig Evan Rademaker Company insiderDirector · last 1 Oct 20250 · 0
David Spencer Soffer Company insiderDirector · last 1 Oct 20250 · 0
Tevi David Troy Company insiderDirector · last 1 Oct 20250 · 0
Thomas Martin Kuendig Company insiderDirector · last 1 Oct 20250 · 0
John Simard Company insiderChief Executive Officer · last 17 Mar 20250 · 20
Donald H. Macadam Company insiderDirector · last 20 Jun 20240 · 0
Jan-Paul Waldin Company insiderDirector · last 20 Jun 20240 · 0
Peter Libby Company insiderDirector · last 20 Jun 20240 · 0
W. Thorpe McKenzie Company insiderDirector, 10% owner · last 20 Jun 202410 · 19
Sushma Shivaswamy Company insiderChief Scientific Officer · last 10 Feb 20230 · 3
Queena Han Company insiderVP Finance & HR · last 19 Nov 20210 · 13
Street Financial S.a. Bay Company insider10% owner · last 18 Dec 20200 · 3

Same industry

MRNA ModernaLeading+167%
IOVA Iovance BiotherapeuticsLeading+141%
ABCL AbCellera BiologicsLeading+57%
ENTX Entera BioLeading+52%
HALO Halozyme TherapeuticsLeading+48%
XERS Xeris Biopharma HoldingsLeading+47%
XNCR XencorLeading+41%
HELP Helus PharmaLeading+39%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-39.2%
Share count trendFY 2025 · to 13 Mar 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$125.6M
Free cash flowFY 2025 · to 31 Dec 2025−$40.2M

Analyst forecasts

No analyst forecasts yet.